How Much Bacteriostatic Water to Add: Volume, Concentration and the Arithmetic
The diluent volume sets the concentration of your preparation and nothing else — it cannot change how much peptide is in the vial. Why that matters, and where the practical limits sit.
There is no single correct volume of diluent for a given vial, and the question as usually asked contains a hidden assumption worth dismantling first: that there is a right answer the vial itself determines. There is not. The volume you add determines the concentration of the resulting solution, and concentration is something you choose to suit the preparation you are making.
The One Equation
All of it reduces to a single relationship: concentration equals mass divided by volume. A 10 mg vial reconstituted with 1 mL of diluent gives 10 mg/mL. The same vial with 2 mL gives 5 mg/mL. With 5 mL, 2 mg/mL. The peptide mass in the vial is fixed at whatever the certificate of analysis says it is; the volume is the variable you control; concentration is the output.
Adding more diluent does not give you more peptide, and adding less does not give you less. A 10 mg vial contains 10 mg whether you dissolve it in 1 mL or 10 mL. The only thing that changes is how much solution each milligram is spread through.
That sounds obvious written down, and it is the single most common conceptual error on this subject. A great deal of confusion in forum discussion comes from treating the diluent volume as though it affected quantity rather than concentration.
Our reconstitution calculator does this arithmetic directly, including the reverse case — working back from a target concentration to the volume required.
Choosing a Target Concentration
Since volume is a choice, the useful question becomes what concentration the preparation should be. Several considerations pull in different directions.
- Solubility sets a hard ceiling. Every sequence has a concentration above which it will not fully dissolve in a given diluent, and pushing against that limit produces incomplete dissolution, visible particulate, or aggregation that is not visible at all. Where a datasheet or certificate gives a solubility figure, that figure is the real constraint
- Measurement precision sets a practical floor on volume. Very small volumes are hard to transfer accurately, and pipetting error is proportionally worse the smaller the volume — a 2% error on 500 µL is a different matter from the same absolute error on 20 µL
- The requirements of whatever the solution feeds into. An assay with a defined working concentration range is far easier to serve from a stock prepared with that range in mind than from one that needs serial dilution at every use
- How the material will be divided. A concentration that produces awkward aliquot volumes creates handling error at every subsequent step
The general-purpose convention of reconstituting to a round figure — 1 mg/mL, 2 mg/mL, 5 mg/mL — exists because round stock concentrations make every downstream dilution easier to get right, and dilution arithmetic is where mistakes actually happen. There is nothing magic about the numbers; the benefit is cognitive.
Purity, Net Peptide Content and What the Label Mass Means
A subtlety that matters for any calculation intended to be accurate rather than approximate: the mass printed on a vial is not necessarily the mass of peptide in it. A 10 mg vial at 98% purity with a net peptide content of, say, 85% contains appreciably less than 10 mg of the peptide itself, with the remainder being counter-ions, residual water and residual solvent.
For many research purposes an approximation is fine and this can be ignored. Where the concentration needs to be known rather than estimated, it cannot. The distinction between purity and net peptide content, and how to find both on a certificate, is set out in net peptide content explained — and how to account for it in a calculation is in dosage calculation principles.
What Goes Wrong at the Extremes
Both ends of the range have characteristic failure modes, and they are not symmetrical.
Too little diluent, meaning too high a target concentration, risks exceeding solubility. The visible version is powder that will not dissolve or a cloudy solution. The invisible and more dangerous version is material that appears to dissolve but has partially aggregated, which can reduce effective concentration in an assay without any outward sign. Adding further diluent after the fact often does not fully reverse aggregation once it has occurred.
Too much diluent, meaning too low a concentration, rarely causes a chemical problem but creates two practical ones. First, you have committed the whole vial to a dilute solution, and solution is the unstable state — a large volume of dilute material has a shorter useful life than the same peptide would have had dry, and you cannot undo it. Second, very dilute peptide solutions are more prone to adsorption losses onto vial and pipette surfaces, which matters proportionally more the less peptide there is.
The asymmetry is worth internalising: over-concentration risks a wrong result, over-dilution mostly risks waste and a shorter window. The stability consequences of committing material to solution are covered in how long peptides last.
Does the Diluent Choice Change the Volume?
Not the arithmetic, no — 2 mL is 2 mL whether it is sterile water or bacteriostatic water, and the resulting concentration is identical. What the diluent choice changes is how long the resulting solution can be relied on and how many times the vial can reasonably be entered, which feeds back into how much you should make at once.
This is the practical link between the two decisions. A preparation intended for single use argues for a smaller volume in preservative-free diluent; one intended to be drawn from repeatedly argues for a preservative-containing diluent and a volume matched to the number of expected entries. The comparison is in bacteriostatic vs sterile water, and the in-use timeframes in bacteriostatic water shelf life.
Technique, Briefly
The volume is only half the operation. How the diluent is introduced affects whether the material survives it.
- Let the vial reach room temperature before opening — a cold vial condenses atmospheric moisture onto the powder
- Run the diluent down the inner wall of the vial rather than directly onto the lyophilised cake
- Swirl gently; never vortex vigorously. Mechanical shear drives aggregation, which is the failure mode you cannot see
- Inspect against light before use. Clear to slightly opalescent is expected; persistent cloudiness or visible particulate is not
- Aliquot immediately, and label every aliquot with compound, concentration, diluent and date
The full procedure is in our reconstitution guide.
A Note on Compound-Specific Advice
A large share of the search traffic on this topic asks for a specific volume for a specific compound at a specific vial size. We deliberately do not publish those tables. The reason is not coyness: a volume figure tied to a named compound is only meaningful alongside an intended concentration, and divorced from that it reads as a protocol — which for research material supplied for laboratory use is not something a supplier should be writing.
What we can give you is the arithmetic, the constraints that bound it, and a calculator that will produce the number for whatever target concentration your work requires. Where a compound has a documented solubility limit, it appears on its certificate of analysis — every batch we have shipped is published and checkable by lot number at /verify.
Common Questions
How much bacteriostatic water should I add to a 10mg vial?
That depends entirely on the concentration you want, because volume sets concentration and nothing else. 1 mL of diluent in a 10 mg vial gives 10 mg/mL; 2 mL gives 5 mg/mL; 5 mL gives 2 mg/mL. Choose the concentration your preparation requires, bounded by the sequence's solubility limit at the top end and measurement precision at the bottom, then use our calculator to get the volume.
Does adding more bacteriostatic water give me less peptide?
No. The mass of peptide in the vial is fixed regardless of diluent volume — a 10 mg vial contains 10 mg whether dissolved in 1 mL or 10 mL. More diluent means lower concentration, spread across more solution. This is the most common misunderstanding on the subject.
What happens if you use too much bacteriostatic water?
Rarely a chemical problem, but two practical ones: you have committed the whole vial to dilute solution, and solution is the unstable state, so the useful window is shorter than it would have been dry. Very dilute solutions are also more prone to adsorption losses onto vial and pipette surfaces.
What happens if you use too little bacteriostatic water?
You risk exceeding the sequence's solubility limit. The visible version is powder that will not dissolve or a cloudy solution; the more dangerous version is material that appears dissolved but has partially aggregated, reducing effective concentration with no outward sign. Adding more diluent afterwards often does not fully reverse it.
Is there a standard reconstitution volume?
No standard, but a common convention of reconstituting to round stock concentrations — 1, 2 or 5 mg/mL — because round figures make every downstream dilution easier to calculate correctly. The benefit is reducing arithmetic error, not anything chemical.
Does the mass printed on the vial equal the mass of peptide?
Not exactly. Purity and net peptide content both reduce it — the remainder is counter-ions, residual water and residual solvent. For approximate work this can be ignored; where concentration needs to be known rather than estimated, it cannot. See net peptide content explained.
Does it matter whether I use bacteriostatic or sterile water for the volume calculation?
Not for the arithmetic — 2 mL gives the same concentration either way. The diluent choice affects how long the solution can be relied on and how many times the vial can reasonably be entered, which in turn should influence how much you prepare at once.